Find out more about Weiguang Zeng's experience
Weiguang Zeng's highlights
FEATURED Journal article
Abstract 3502: AXA-042 - a novel systemic TLR2/6 agonist for anti-tumor therapy
Read moreWeiguang Zeng's selected work
Lead Selection for Respiratory Program
Research Contracts
TLR2-mediated activation of innate responses in the upper airways confers antiviral protec..
Journal article
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract..
Journal article
Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose M..
Journal article
Modular platforms for the assembly of self-adjuvanting lipopeptide-based vaccines for use ..
Journal article
Geometry of a TLR2-Agonist-Based Adjuvant Can Affect the Resulting Antigen-Specific Immune..
Journal article
Weiguang Zeng's selected work
Patents
Displaying the most recent patent by Weiguang Zeng.
Projects
Displaying the 8 most recent projects from 8 for Weiguang Zeng.
Project Types
3
Research Contracts
3
Research Grant
2
Internal Research Grant
Scholarly Works
Displaying the 10 most recent scholarly works from 102 for Weiguang Zeng.
Honours, Awards and Fellowships
Accepted
Credentials
Positions
Senior Research Officer Nh&Mrc
Microbiology and Immunology
Education
Bachelor of Science
Jiangxi Medical College
Master of Science
National Institutes for Food and Drug Control
Doctor of Philosophy
Eberhard-Karls-Universitaet Tuebingen